By Gina Shaw
More than half of people who still have uncontrolled HIV despite ongoing treatment have a HIV strain of the virus that is resistant to tenofovir, a mainstay of antiretroviral therapy, according to a report published in Lancet Infectious Diseases online on Jan. 28 (http://dx.doi.org/10.1016/S1473-3099(15)00536-8).
More than half of people who still have uncontrolled HIV despite ongoing treatment have a HIV strain of the virus that is resistant to tenofovir, a mainstay of antiretroviral therapy, according to a report published in Lancet Infectious Diseases online on Jan. 28 (http://dx.doi.org/10.1016/S1473-3099(15)00536-8).
“This result is disconcerting, because it had previously been thought that tenofovir might be less prone to development of drug resistance than other